The ADC binds Trop-2 on target cells, is internalized, and releases SN-38 (a topoisomerase I inhibitor) that stabilizes Topo I-DNA cleavage complexes, causing DNA strand breaks, S-phase arrest, and apoptosis; a bystander effect may also occur.